Pandion Therapeutics competitors and similar companiesClear all

Pandion Therapeutics's competitors and similar companies include ImCheck Therapeutics, Integral Molecular, Rubius Therapeutics and Atara Biotherapeutics.

	Pandion Therapeutics Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.	ImCheck Therapeutics ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .	Integral Molecular Integral Molecular is a biotechnology company that provides membrane protein solutions.	Rubius Therapeutics Rubius is developing a new class of drugs, Red-Cell Therapeutics™.	Atara Biotherapeutics Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases.
Founding Date	Founding Date 2017	Founding Date 2015	Founding Date 2001	Founding Date 2013	Founding Date 2012
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy
Locations	Locations Cambridge, US HQ Watertown, US	Locations Marseille, FR HQ	Locations Philadelphia, US HQ	Locations Cambridge, US HQ Smithfield, US	Locations South San Francisco, US HQ Reykjavík, IS Mocejón, ES Zug, CH Aurora, US New York, US Thousand Oaks, US
Employees	Employees 665% increase	Employees 48	Employees 851% decrease	Employees 17423% increase	Employees 39326% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 18.9 m	Valuation ($) 428 m
Twitter followers	Twitter followers 266	Twitter followers 551	Twitter followers 148	Twitter followers 1.6 k	Twitter followers 1.9 k
Number of tweets (last 30 days)	Number of tweets (last 30 days) 6	Number of tweets (last 30 days) 3	Number of tweets (last 30 days) 1	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 9
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 6.7	Average likes per tweet (last 30 days) 3.3	Average likes per tweet (last 30 days) 1	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 4.7
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 66.67%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 100%
Alexa Website Rank	Alexa Website Rank N/A	Alexa Website Rank 605980	Alexa Website Rank 290554	Alexa Website Rank 584094	Alexa Website Rank 296691
Employee Rating	Employee Rating 3.7	Employee Rating N/A	Employee Rating 4.4	Employee Rating 4.4	Employee Rating 3.9
Financial
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ($196.5m) (FY, 2021)	Net income ($340.1m) (FY, 2021)
Funding
Latest funding round	Latest funding round $ 80m (over 2 years ago)	Latest funding round $ 53.2m (almost 3 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 138m	Total funding raised $ 76.1m	Total funding raised N/A	Total funding raised $ 245m	Total funding raised $ 61.8m